# Harnessing Bacterial Lipid Coatings on Gold Nanoparticles for Enhanced Cell Adhesion Applications

**Authors:** Soroosh Gharehgozlo, Shakil Ahmed Polash, Kalpani A. Mirihana, Jakub Matusiak, Lauren Giles, Pierre Vaillant, Shreehari Kodakkat, Serena Ch'ng, Rowan Penman, Samuel Cheeseman, Lydon Alexandrou, Jitraporn Vongsvivut, Andrew J. Clulow, Andrew J. Christofferson, Paul A. Ramsland, Saffron J. Bryant, Aaron Elbourne

PMC · DOI: 10.1002/smsc.202500584 · Small Science · 2026-02-17

## TL;DR

This paper explores using bacterial membrane lipids to coat gold nanoparticles, which improves their adhesion to bacteria and could enhance drug delivery to drug-resistant pathogens.

## Contribution

The novel use of isolated bacterial membrane lipids to coat gold nanoparticles for improved cell adhesion and drug delivery is introduced.

## Key findings

- BLC-AuNPs showed significantly increased particle-cell adhesion compared to bare AuNPs.
- Lipid-coated nanoparticles improved particle distribution and surface coverage on bacterial cells.

## Abstract

Antimicrobial resistance (AMR) is a global health challenge responsible for millions of deaths annually. Hence, there is an urgent need for improved strategies to combat AMR. Nanoparticle (NP)‐based drug delivery has shown promise for enhancing the efficacy of conventional antibiotic treatments. Moreover, lipid functionalization of NP surfaces can enhance drug loading, colloidal stability, and specificity. Cell membrane vesicles as the outer shell coating for NPs provokes a unique interaction between fabricated NPs and their respective parent bacteria. Despite numerous studies having investigated the use of bacterial extracellular vesicle coatings for drug delivery, to the best of our knowledge, the potential of isolated bacterial membrane lipids has not yet been explored. This study investigates how particle‐cell adhesion changes when gold NPs (AuNPs) coated with bacterial membrane lipids are re‐introduced to their original parent cells. Hence, bacterial lipid coated AuNPs (BLC‐AuNPs) were constructed using AuNPs in conjunction with membrane lipids harvested from Escherichia coli. Compared with bare AuNPs, BLC‐AuNPs showed significant increase in particle‐cell adhesion upon re‐exposure confirmed by confocal and electron microscopy. Lipid coating also improved particle distribution and surface coverage on bacterial cells. These findings suggest that bacterial membrane lipid coating provides an effective biomimetic strategy, enhancing drug deliveryto drug resistant pathogens.

Preparation and application of bacterial lipid–coated gold nanoparticles (BLC‐AuNPs).© 2026 WILEY‐VCH GmbH

## Linked entities

- **Species:** Escherichia coli (taxon 562)

## Full-text entities

- **Genes:** BLC [NCBI Gene 20490448]
- **Diseases:** AMR (MESH:D060467), infection (MESH:D007239), DLS (MESH:D020795), deaths (MESH:D003643), bacterial infection (MESH:D001424)
- **Chemicals:** DCM (MESH:D008752), N2 (MESH:D009584), carbon (MESH:D002244), ester (MESH:D004952), CH3OH (MESH:D000432), Au (MESH:D006046), NaCl (MESH:D012965), trisodium citrate (MESH:C514290), rhodamine (MESH:D012235), O (MESH:D010100), stainless-steel (MESH:D013193), GP (MESH:D020404), POPE (MESH:C057561), salt (MESH:D012492), phosphate (MESH:D010710), copper (MESH:D003300), Ge (MESH:D005857), silver (MESH:D012834), MCT (MESH:C104191), ethanol (MESH:D000431), cardiolipin (MESH:D002308), amide (MESH:D000577), zinc oxide (MESH:D015034), water (MESH:D014867), Phospholipid (MESH:D010743), PG (MESH:D010715), thiol (MESH:D013438), fatty acid (MESH:D005227), CL (MESH:D002713), PE (MESH:C483858), silicon (MESH:D012825), HAuCl4.xH2O (-), aluminum (MESH:D000535), Na (MESH:D012964), silica (MESH:D012822), sodium citrate (MESH:D000077559), 2,5-dihydroxybenzoic acid (MESH:C010925), H (MESH:D006859), glutaraldehyde (MESH:D005976), ROS (MESH:D017382), Formaldehyde (MESH:D005557), 4',6-diamidino-2-phenylindole (MESH:C007293), Citrate (MESH:D019343), C2H7NO2 (MESH:C018824), CHCl3 (MESH:D002725), LPS (MESH:D008070), Lipid (MESH:D008055)
- **Species:** Escherichia coli (E. coli, species) [taxon 562], Bacteria Latreille et al. 1825 (Bacteria stick insect, genus) [taxon 629395], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** G7117C, G7116A, G7167A, C by the 35
- **Cell lines:** S2 — Drosophila melanogaster (Fruit fly), Spontaneously immortalized cell line (CVCL_Z232), DH5alpha — Drosophila hydei (Fruit fly), Spontaneously immortalized cell line (CVCL_Z531)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12911120/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12911120/full.md

## References

120 references — full list in the complete paper: https://tomesphere.com/paper/PMC12911120/full.md

---
Source: https://tomesphere.com/paper/PMC12911120